- Q4 2023 Lineage Cell Therapeutics Inc Earnings Call TranscriptMar 07, 2024Earnings
- Q3 2023 Lineage Cell Therapeutics Inc Earnings Call TranscriptNov 09, 2023Earnings
- Q2 2023 Lineage Cell Therapeutics Inc Earnings Call TranscriptAug 10, 2023Earnings
- Q1 2023 Lineage Cell Therapeutics Inc Earnings Call TranscriptMay 11, 2023Earnings
- Q4 2022 Lineage Cell Therapeutics Inc Earnings Call TranscriptMar 09, 2023Earnings
- Q3 2022 Lineage Cell Therapeutics Inc Earnings Call TranscriptNov 10, 2022Earnings
- Q2 2022 Lineage Cell Therapeutics Inc Earnings Call TranscriptAug 11, 2022Earnings
- Q1 2022 Lineage Cell Therapeutics Inc Earnings Call TranscriptMay 12, 2022Earnings
- Lineage Cell Therapeutics Inc at B Riley Neuro & Ophthalmology Conference (Virtual) TranscriptApr 27, 2022
- Lineage Cell Therapeutics Inc at Noble Capital Markets Investor Conference (Virtual) TranscriptApr 20, 2022
- Q4 2021 Lineage Cell Therapeutics Inc Earnings Call TranscriptMar 10, 2022Earnings
- Lineage Cell Therapeutics Inc To Discuss Worldwide OpRegen Collaboration Call TranscriptDec 20, 2021
- Q3 2021 Lineage Cell Therapeutics Inc Earnings Call TranscriptNov 10, 2021Earnings
- Lineage Cell Therapeutics Inc at B Riley Fall Growth Biotech Best Ideas (Virtual) TranscriptOct 18, 2021
- Q2 2021 Lineage Cell Therapeutics Inc Earnings Call TranscriptAug 12, 2021Earnings
- Lineage Cell Therapeutics Inc at Raymond James Human Health Innovation Conference (Virtual) TranscriptJun 22, 2021
- Lineage Cell Therapeutics Inc Webinar Featuring External Therapeutic Area Experts TranscriptJun 10, 2021
- Q1 2021 Lineage Cell Therapeutics Inc Earnings Call TranscriptMay 13, 2021Earnings
- Q4 2020 Lineage Cell Therapeutics Inc Earnings Call TranscriptMar 11, 2021Earnings
- Lineage Cell Therapeutics Inc Corporate Analyst Meeting TranscriptFeb 22, 2021
- Lineage Cell Therapeutics, Inc. - Special Call TranscriptNov 17, 2020
- Q3 2020 Lineage Cell Therapeutics Inc Earnings Call TranscriptNov 04, 2020Earnings
- Q2 2020 Lineage Cell Therapeutics Inc Earnings Call TranscriptAug 06, 2020Earnings
- Lineage Cell Therapeutics, Inc. - Special Call TranscriptJun 08, 2020
- Lineage Cell Therapeutics, Inc. - Special Call TranscriptMay 11, 2020
- Q1 2020 Lineage Cell Therapeutics Inc Earnings Call TranscriptMay 07, 2020$1.07Earnings
- Q4 2019 Lineage Cell Therapeutics Inc Earnings Call TranscriptMar 12, 2020$1.07Earnings
- Lineage Cell Therapeutics Inc at Solebury Trout KOL Day TranscriptNov 15, 2019
- Q3 2019 Lineage Cell Therapeutics Inc Earnings Call TranscriptNov 12, 2019$1.07Earnings
- Q2 2019 BioTime Inc Earnings Call TranscriptAug 08, 2019$1.07Earnings
- Q1 2019 BioTime Inc Earnings Call TranscriptMay 09, 2019$1.25Earnings
- Q4 2018 BioTime Inc Earnings Call TranscriptMar 14, 2019$1.14Earnings
Lineage Cell Therapeutics Inc Corporate Analyst Meeting Transcript
Good afternoon, everyone. My name is Jason McCarthy. I am the Head of Biotechnology Equity Research with Maxim Group. And it is with great pleasure to welcome you to today's virtual event, featuring Lineage Cell Therapeutics and an in-depth discussion on the company's allogeneic cell therapy program, OPC1, for treating spinal cord injury.
As a research analyst, as many of my colleagues in the business would tell you, there are any number of therapeutic categories to cover, each with exciting companies and science and medicine that could be and often is transformative. And you could look at oncology, inflammatory disease, gene therapy, NASH. And what about Alzheimer's disease? It's been a pretty hot-button topic just in the last couple of weeks alone.
And these are just a handful of spaces, and all are different. But what links them is that each has had its areas of tremendous success. And with it sometimes comes parabolic-like rises in valuations. So my question is what about cell therapy?
Sure, we can always
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)